183 related articles for article (PubMed ID: 8679442)
1. Expression of NM23 in human melanoma progression and metastasis.
Easty DJ; Maung K; Lascu I; Véron M; Fallowfield ME; Hart IR; Bennett DC
Br J Cancer; 1996 Jul; 74(1):109-14. PubMed ID: 8679442
[TBL] [Abstract][Full Text] [Related]
2. Expression of metastasis suppressor gene product, nm23 protein, is not inversely correlated with the tumour progression in human malignant melanomas.
Saitoh K; Takahashi H; Yamamoto M; Kishi H; Parsons PG
Histopathology; 1996 Dec; 29(6):497-505. PubMed ID: 8971556
[TBL] [Abstract][Full Text] [Related]
3. Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: significance and implications in tumor biology.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(1A):505-11. PubMed ID: 9066703
[TBL] [Abstract][Full Text] [Related]
4. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
[TBL] [Abstract][Full Text] [Related]
5. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model.
Ma D; Luyten GP; Luider TM; Jager MJ; Niederkorn JY
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2293-301. PubMed ID: 8843913
[TBL] [Abstract][Full Text] [Related]
6. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of nm23 protein expression in malignant melanoma. An immunohistochemical study.
van den Oord JJ; Maes A; Stas M; Nuyts J; De Wever I; De Wolf-Peeters C
Melanoma Res; 1997 Apr; 7(2):121-8. PubMed ID: 9167178
[TBL] [Abstract][Full Text] [Related]
8. Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion.
Marone M; Scambia G; Ferrandina G; Giannitelli C; Benedetti-Panici P; Iacovella S; Leone A; Mancuso S
Br J Cancer; 1996 Oct; 74(7):1063-8. PubMed ID: 8855975
[TBL] [Abstract][Full Text] [Related]
9. A low NM23.H1 gene expression identifying high malignancy human melanomas.
Caligo MA; Grammatico P; Cipollini G; Varesco L; Del Porto G; Bevilacqua G
Melanoma Res; 1994 Jun; 4(3):179-84. PubMed ID: 7919963
[TBL] [Abstract][Full Text] [Related]
10. NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival.
Xerri L; Grob JJ; Battyani Z; Gouvernet J; Hassoun J; Bonerandi JJ
Br J Cancer; 1994 Dec; 70(6):1224-8. PubMed ID: 7981081
[TBL] [Abstract][Full Text] [Related]
11. The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival.
Döme B; Somlai B; Tímár J
Anticancer Res; 2000; 20(5C):3971-4. PubMed ID: 11268486
[TBL] [Abstract][Full Text] [Related]
12. The role of nm23 in melanoma progression and its prognostic significance.
Betke H; Korabiowska M; Brinck U; Trybus-Gałuszka H; Kellner S; Okoń K; Stachura J; Droese M
Pol J Pathol; 1998; 49(2):93-6. PubMed ID: 9798412
[TBL] [Abstract][Full Text] [Related]
13. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line.
Baba H; Urano T; Okada K; Furukawa K; Nakayama E; Tanaka H; Iwasaki K; Shiku H
Cancer Res; 1995 May; 55(9):1977-81. PubMed ID: 7728768
[TBL] [Abstract][Full Text] [Related]
14. Expression of NM23 protein in acquired melanocytic nevi, malignant melanoma and metastases of malignant melanoma: an immunohistological assessment in human skin.
Reichrath J; Seyfried P; Braun R; Müller SM; Baum HP; Bahmer FA
Dermatology; 1997; 194(2):136-9. PubMed ID: 9094461
[TBL] [Abstract][Full Text] [Related]
15. Modulators of intracellular Ca2+ and the calmodulin inhibitor W-7 alter the expression of metastasis-associated genes MTS1 and NM23 in metastatic variants of the B16 murine melanoma.
Parker C; Sherbet GV
Melanoma Res; 1992 Dec; 2(5-6):337-43. PubMed ID: 1337998
[TBL] [Abstract][Full Text] [Related]
16. Phorbol 12-myristate 13-acetate enhances nm23 gene expression in murine melanocytes but not in syngeneic B16-BL6 melanoma variants.
Huijzer JC; McFarland M; Niles RM; Meadows GG
J Cell Physiol; 1996 Mar; 166(3):487-94. PubMed ID: 8600152
[TBL] [Abstract][Full Text] [Related]
17. Expression of the nm23 metastasis-suppressor gene product in skin tumors.
Kanitakis J; Euvrard S; Bourchany D; Faure M; Claudy A
J Cutan Pathol; 1997 Mar; 24(3):151-6. PubMed ID: 9085150
[TBL] [Abstract][Full Text] [Related]
18. Expression of the tumor metastatic suppressor gene in mouse melanoma model: inverse association to metastatic potential.
Meng L
J Tongji Med Univ; 1998; 18(1):28-32, 36. PubMed ID: 10806798
[TBL] [Abstract][Full Text] [Related]
19. Expression of nm23 in cell lines derived from patients with metastatic renal cell carcinoma.
Walther MM; Anglard P; Gnarra J; Pozzatti R; Venzon D; de la Rosa A; MacDonald NJ; Steeg PS; Linehan WM
J Urol; 1995 Jul; 154(1):278-82. PubMed ID: 7776445
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical analysis of nm23 gene product expression in uveal melanoma.
Greco IM; Calvisi G; Ventura L; Cerrito F
Melanoma Res; 1997 Jun; 7(3):231-6. PubMed ID: 9195562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]